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1 Introduction
Science, technology and innovation are currently
major areas of investment for development agencies
and the subject of numerous development initiatives.
One of the key issues often discussed in relation to
efforts to create science for development is who
should make decisions about new technologies and
innovation and whether more or less participation is
needed.
Participation can be viewed in two ways. As a
mechanism to ensure increased democracy in
decision-making about development and as a way of
achieving other social and economic development
goals, economic growth, or better ways of delivering
health and education for instance. These two
approaches can be thought of as an ‘entitlement
view’ on the one hand and a ‘productivity view’ on
the other (Mosse 2005).1 Both views are widely used
and both have very substantial literatures and
theoretical constructs that underpin them.
Participation is drawn into debates about
technological innovation and debates about science
and technology in many ways in a wide variety of
settings. The quality and purpose of participation is
often contentious. In particular, discussion about
efforts to create forms of direct democracy or
participative democracy in relation to science and
technology has been bitterly contested and
voluminous (Irwin and Wynne 2004; Leach et al.
2005; Jasanoff 2007). Recent work highlights
problems in trying to use ‘participation’ as a wide-
ranging decision-making tool about technologies in
the abstract. Various authors argue strongly against
advocating the use of participative techniques simply
on the grounds that they lead to increased
democracy (Tait 2004). Using the example of the GM
Nation debate in the UK, Tait argues that
‘participation’ and instances of ‘deliberative
democracy’ are often smokescreens for special issue
groups to exert control. This theme is also dealt with
in relation to biotechnology debates by Taverne
(2005). Other work has highlighted instances where
participation is used to legitimate science and
technology-based development projects and in
communication to funders but has not delivered
significant opportunities for broader engagement
over the way those projects are developed and run
(Chataway and Smith 2006). The more general point
here is that participation can involve changed
epistemologies in relation to knowing what different
groups feel and need but may well not be
democratic or involve substantial institutional change.
This is an argument articulated elegantly by Mohan
(2007). Participation events do not necessarily
represent significant advances in deliberative
democracy. They often fail in terms of both
productivity and entitlement.
Detailed investigation into the way participation is
encouraged and used is key to more nuanced
perspectives regarding the value of participation. This
article is a tentative and exploratory attempt to think
about how we can develop tools to evaluate
participation in the context of broader institutional
development in the area of science, technology and
innovation rather than as one-off ‘events’,
smokescreens or vehicles for legitimation.
The article draws on a case study of a high-profile
initiative which has communication and participation
at its core. The International AIDS Vaccine Initiative
(IAVI) seeks to develop AIDS vaccines while building
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demand for vaccines as a means to ensure sufficient
funds exist to purchase vaccines as they are
developed to market. IAVI is rooted in traditions of
innovation and market chain approaches, aware of
the dangers of technology-led strategies and keen to
engage a wide variety of stakeholders both in the
development of an effective vaccine and in
widespread distribution of an accepted and popular
vaccine. We argue that IAVI views participation as
central to its communications efforts and explain
why this is the case.
This article suggests that analysis of participation and
communication might benefit from revisiting Albert
Hirschman’s ideas of exit, voice and loyalty. We give
some suggestions of how this framework might be
used to explore institutional aspects of participation
and communications in the case of IAVI.
2 Participation and engagement: creating ‘voice’
Ideally the ‘entitlement view’ and the ‘productivity
view’ of participation become one and the same.
More participation, more inclusion, more
accountability leads to improved performance and
‘better development’ in the short run and with
regard to particular projects, and lays the basis for
better decision-making and a more solid grounding
for development in the longer term. That can and
does happen. But of course it does not always
happen. Entitlement and productivity as a result of
participation can happen independently of each
other or not at all.
Development, as a process of change, has conflict at
its heart. One way of looking at participation is as a
channel for voicing dissent – it can be seen as a way
of ensuring engagement even in the case of
disagreement. Hirschman (1970) offered a conceptual
framework for understanding the value of
participation and engagement in his seminal work,
‘Exit, Voice and Loyalty’: Responses to decline in
firms, organisations and states. Hirschman’s is an
explicit attempt to create an interdisciplinary
understanding of how effective institutions get
created and draws on concepts and tools from
economics and politics. Economists tend to value
‘exit’, the ability to choose and reject options to buy
products and services, as a way of promoting
competition and better institutions. But not all
situations lend themselves to this market-based
mechanism and Hirschman posits ‘voice’ and
engagement as another mechanism, rooted in the
traditions of politics and political science as an
equally important way to advance institutional
development. Put very crudely, the opportunity to
participate, to engage, gives people the opportunity
to voice their opinions and, if the institutional
conditions exist, and given a degree of loyalty to the
institution, firm or initiative, improvement can and
often does result from participation. A balance
between opportunities for ‘voice’, possibilities for
‘exit’ and efforts to secure ‘loyalty’ are fundamentals
in creating effective organisations. Some
organisations and exits are more responsive and
susceptible to either exit or voice, in part depending
on the degree of loyalty which people attach to
them (firms for instance are more generally
susceptible to exit than political parties), but both
have crucial roles to play in improving different kinds
of organisations and institutions.
The process of creating conditions for engagement
and ‘voice’, as thought by Hirschman, involves both
‘productivity’ and ‘entitlement’ aspects of
participation. His thoughts are echoed in more recent
literature on innovation. For example, the idea of
‘feedback’ between researchers, producers, users and
consumers has replaced the ‘linear model’ as a mantra
behind which innovation scholars and policymakers
now line up. This is one articulation of the need for
voice and much of the innovation systems literature
deals with the value of interaction and participation in
this sense (Lundvall 1992; Hall 2005).
This is different from the idea of having structured,
organised forms of participation, and we suggest
that those types of activities are a necessary or even
sufficient condition for technological development to
take place and have positive impacts. Things are
always contingent on context and the right
innovation in the right place at the right time can
unlock development benefits in a way that any
number of participative exercises cannot. In cases
where the market operates or where choice exists,
‘exit’ in Hirschman’s terms, provides an effective way
of determining the popularity and desirability of
what an organisation produces and can bring about
positive impacts. For example, there were very few
participation exercises around the introduction of
mobile phones in developing countries, and little
suggestion that participation exercises are necessary
and yet people in Africa and elsewhere have adopted
this technology rapidly and it is having multiple
impacts on the way in which people are able to
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conduct business and organise life. In these cases,
where the institutional infrastructure allows for
choice and there is some degree of competition, the
threat of exit (people voting with their purchasing
power) may be sufficient to inspire improvements in
product delivery and services.
Still, as Hirschman points out, in many institutional
contexts in both developing and developed countries,
market institutions may not be well developed or not
appropriate and different organisational forms need
to be established to facilitate improvement. It is here
that ‘voice’ needs to be thought about. This analysis
is critically relevant to improving science and
technology-based innovation in developing countries.
Creating effective participation and engagement in
these circumstances is difficult and challenging but
often essential to success. Our understanding of
what ‘works’, of what is legitimate and of what
constitutes good practice remains relatively weak.
We need to develop more refined perspectives on
participation, different modes of participation and
their relationship to institutional reform, citizenship
and democratic practices.
3 Participation, communication and innovation
systems
One way in which to refine thinking about
participation might be to clarify its relationship to
communication strategies. Without communication,
participation is redundant. However, the broader
communications flows between organisations and
institutions are often ignored in studies of
participation. As Hickey and Mohan have pointed
out, participation is often viewed as a contained
event rather than as part of broader political
developments and in terms of a political channel
within and between organisations (Hickey and
Mohan 2004; Mohan 2007).
We suggest that looking at the relationship between
communication and participation strategies of a
particular innovation and development initiative is
useful for the following two reasons:
1 Most development interventions have a purposive
as well as normative aspect. They are about
participation as ‘productivity’ as well as
‘entitlement’; understanding that in most cases
participation is used as a device to communicate
the usefulness of certain approaches or ideas as
well as to listen and learn and be led by local
ideas, is a more accurate picture of the majority
of development interventions.
2 The extent to which participation is embedded in
communication strategies and channels of
communication within and between organisations
is vital to understanding the limits and/or
potential of participation. If grassroots
participation is viewed as an isolated event rather
than an integral part of communication flows it is
much less significant than if incorporated into an
approach which views it as an ongoing effort to
adjust power relations.
Thus talking about communication strategies in
relation to development initiatives acknowledges
that there is an internal purpose and agenda which
run alongside and is intimately aligned to
participation activities. It also helps us to see
participation as part of broader organisational and
institutional set-ups. Adopting this line of thought, a
number of questions might be asked of particular
initiatives and organisations which involve
participation exercises, including the following: Is
participation a genuine attempt to let grassroots and
other influences shape the strategy of an
organisation (are communication channels refigured
around participation)? This could be thought of as
‘communication for participation’. Or is participation
a way of trying to create legitimacy without
substantially altering the broader agenda? This could
be thought of as ‘participation for communication’.
Thinking about a system and institutions very broadly,
participation then may result in shaping the
organisation to work in a more systemic way, or it
may influence the system to the needs and agendas
of the organisation. It may of course do both of
these things.
More general discussions and frameworks for looking
at participation are certainly essential but there are
particular ways in which they configure around issues
of science, technology and innovation. Innovation
systems’ thinking constitutes another body of work
that can help to situate participative activities in the
broader context of institutional development.
Innovation systems’ thinking is predicated on the idea
that innovation requires networks, linkages and
partnerships. It is predominantly routed in a
‘productivity view’ of participation. Andy Hall et al.
(2001: 794) describe an innovation system as follows:
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At its heart lies the contention that change – or
innovation – results from and is shaped by the
system of organizations and institutions (in the
rules, norms and conventions sense) in particular
locations and points in time. An innovation system
includes organizations involved with research and
the application and adaptation of research
findings, as well as intermediary organizations
that promote knowledge transfer.
The great contribution made by innovation systems is
that it forces us to think about technologies and
innovation in relation to the institutional structures
which they relate to. A whole set of interesting
questions are being asked about how particular
innovations occur within systems and what kind of
interactions are needed to achieve successful
innovation. How are sectoral and national systems
constructed as the result of multiple innovation-
based initiatives which forge their own micro-
systems? These questions that try and relate the
micro and macro through case studies of new
innovations are the subject of interesting work by
evolutionary economists such Metcalfe and others
such as Hall (Metcalfe 2005; Mina et al. 2005; Hall
2005).
Careful case study analysis in this work moves us away
from abstract consideration of participation and
innovation systems and injects the analysis with the
messy reality of ‘trying to get things done’. ‘Trying to
get things done’ is not simply about systems,
innovation or participation, it is also an entirely
political activity; something that the abstraction of
innovation systems approaches does not engage with.
Here, analysis mainly relates to ‘productivity’ views of
participation but what is interesting is that often the
distinction between productivity and entitlement
views begin to break down. Small farmers organised
into groups and for training and enhancement of
technical skills and advice about growing vitamin A-
rich sweet potatoes gain capacity to intervene in
decision-making and ‘voice’ in multiple ways
(Chataway and Smith 2007). These complex
relationships between the more instrumentalist
approaches of innovation systems and the creation of
broader capacities are not well understood or studied.
Our perspective in this article is that one angle from
which to view these complex relationships is from the
perspective of how participation is or is not
integrated into communication strategies and how
concepts of exit, voice and loyalty can shed light on
broader dynamics. With this in mind, we now briefly
look at IAVI.
4 The International AIDS Vaccine Initiative
(IAVI): innovation driven by communication
IAVI is a large international not-for-profit public–
private partnership devoted to creating a preventative
AIDS vaccine. Its headquarters are in New York and it
works in approximately 23 countries, building local
research capacity, primarily to undertake local vaccine
trials, and building awareness and ‘demand’ for an
AIDS vaccine. Although it is a long way from
achieving its core goal of creating and distributing a
vaccine, IAVI has achieved three main aims. First, it
has raised large sums of money, over US$340 million
by 2006. This money has been used to fund the
development of promising vaccine candidates and to
raise awareness about HIV/AIDS and the need for a
vaccine. Second, and intimately connected to the first,
it has created widespread awareness of the potential
impact of vaccines and the role that cutting edge
science and technology can play in the fight against
AIDS in developing countries (Skolnik 2003). IAVI has
put forward the possibility of an HIV/AIDS vaccine,
and awareness of the need for very considerable
investment, on the agenda of every bilateral donor.
Third, it has created capacities in developing countries
both to carry out advocacy in relation to HIV/AIDS
and also to participate in the actual development of
vaccine and in carrying out clinical trials.
Communication is essential to IAVI and a diverse set
of communications activities, from grassroots
advocacy to high level public relations are core
business. For example, in 2000 a photograph of Seth
Berkeley, IAVI’s chief executive officer (CEO),
appeared on the cover of Newsweek magazine, with
a caption ‘Can this man stop AIDS?’. IAVI’s
considered consultations and inputs into discussions
about advanced purchase agreements for AIDS/HIV
vaccines is probably best labelled policy-related
advocacy. However one labels this type of activity, it
is clearly different from the grassroots advocacy that
many development initiatives claim to carry out. But
IAVI has also been extremely active in ‘grassroots
advocacy’ and participation activities. Indeed, in order
to carry out clinical trials in different locations it has
had to undertake groundwork prior to community
involvement in vaccine trials. It educates about
HIV/AIDS in general and always works in partnership
with local grassroots organisations, and has worked
closely with local non-governmental organisations
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(NGOs) and community-based health groups. It has a
strong reputation for the integrity of its work at the
grassroots level (Skolnik 2003; Chataway and Smith
2006). Although IAVI is clear about its mission of
creating and distributing a vaccine, it is also clear that
in order for it to fulfil its mission effectively, it must
work in partnership with groups at all levels and in
particular understand and work in conjunction with
grassroots organisations. This is important in terms of
broader institution building. IAVI is explicitly part of
the broader communities in which it operates and its
approach is in part influenced by those of the
organisations it works with in different contexts.
IAVI has also invested very considerable amounts in
infrastructure and in training in African countries and
has contributed to capacity building in both Africa
and India. We have provided detail about capacity
building in other publications (Chataway and Smith
2006; Chataway et al. 2007a) but to summarise, IAVI
has done the following:
z Built and refurbished laboratories including a
state-of-the-art clinical unit at Uganda Viral
Research Institute (UVRI) and substantially
invested in the Kenya AIDS Vaccine Initiative’s
(KAVI) infrastructure and equipment.
z Created a large network of AIDS vaccine testing
sites and the world’s first consortium of
laboratories for conducting validated HIV immune
response assays.
z Provided funding for running expenses and the
training and updating of scientists’ and
technicians’ knowledge including ongoing training
courses on Good Clinical Laboratory Practice
(GCLP). IAVI works with a core laboratory in
London to ensure that sites are able to follow
GCLP. Training is carried out in London and in
local laboratories.
In Africa, substantial amounts of money have been
invested in infrastructure and in training (Chataway and
Smith 2006). IAVI has worked with speed and
efficiency, combining focused activity with real
evidence of capacity building and engagement with
Southern partners. Importantly, interviewees from
Kenyan, Ugandan and Rwanda facilities all feel that
largely as a result of engagement with IAVI, they have
the potential of turning their units into clinical trials
centres of excellence, dealing not only with HIV/AIDS
vaccine but with a range of drug development projects.
This is an unusual story of capacity building activity.
In India, where technological capacity is relatively
advanced, there is still a need to provide access to
the latest developments at an international level. In
India (as in a number of other developing countries
where IAVI is operational) a Memorandum of
Understanding (MOU) exists with ministries and
research institutes and close relationships with NGOs
and private sector companies are also pursued.
Considerable effort has been put into bringing
together policymakers and private sector companies
in discussion about the role that Indian institutions
could play in research and development efforts and
then in manufacturing efforts should a vaccine result.
5 Communications-led strategy
An interesting question is, why did IAVI pursue this
strategy? Why did it not just focus on creating a vaccine
in the best laboratories in the world and in the shortest
time? Given the urgency of the challenge IAVI
confronts, there would have been an argument for
taking that approach. The answer is not simply that
IAVI decided to be a good citizen in developing
countries. The very hefty investment and the enormous
effort involved in creating partnerships in developing
countries, is not an ‘add on’ to other efforts so much as
it is a consequence of taking communications
extremely seriously and in some sense, letting the
communication concerns drive the work. IAVI is an
organisation driven and dominated by its concern with
communication. And that has led it in interesting
directions with some very interesting results.
As mentioned previously, IAVI is headquartered in
New York. Importantly, the majority of IAVI’s
directors do not have research science backgrounds
and a high proportion of IAVI managers have
experience in advocacy and communications, many
with a mix of private and public sector backgrounds.
IAVI began its work on vaccine development in Kenya.
These efforts were in partnership with KAVI and the
Oxford Medical Research Council laboratory and IAVI
in New York. IAVI at that time did not have a regional
office and could well be characterised at the time as
a US- or ‘Western’-led effort. This danger was
highlighted by an independent review (Skolnik 2003).
It quickly became apparent to IAVI that if it was to
develop local support (which is absolutely essential if a
vaccine is to be distributed effectively) it would have
to work in such a way that it had local partnership at
its core and prioritise local communications as well as
lobbying efforts at the international level.
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As a consequence of this desire to build political
demand and support from the grassroots level up,
IAVI needed to make sure that efforts were seen as
locally appropriate endeavours. The AIDS vaccine
initiative needed to be owned by developing
countries, and compromises and concessions to
capacity building in developing countries had to be
made. IAVI committed to that effort and let it
influence the work it does in fundamental ways.
Commenting on the way in which operations were
established in India, where a MOU was signed with
two government bodies at the outset, one IAVI
interviewee said:
It’s a partnership with governments and we
always accept that … it’s a three way partnership,
NACO [the National AIDS Control Organization]
and ICMR [the Indian Council of Medical
Research] and us and we are the junior partners
and we accept that’. The interviewee went on to
talk about the importance of relationships with
NGOs and civil society, both for operational
purposes and in terms of legitimacy …
‘government told us quite early on that in India if
there was significant opposition in civil society, it
didn’t really matter much what government
wanted or didn’t want, we wouldn’t get to do it
… India is a democratic country and that’s clear.
The strategy of combining advocacy, PR (IAVI’s CEO,
Seth Berkeley, meets regularly with India’s political,
community and medical leaders) and more
participative approaches appears successful in this
case. Close relationships have been forged with
community groups and NGOs and the emphasis on
advocacy and relationship building is noted by an
independent reviewer as having been particularly
strong. One informant noted, ‘If IAVI had not come,
India would not have taken a vaccine initiative so
soon and so strongly’. Another said that ‘vaccines
would have been a non-issue (in India) without IAVI’
(Skolnik 2003).
Apart from commitments to developing
infrastructure in African countries, IAVI’s
communications focus has had other consequences.
For example, in Africa, IAVI conceptualises the
vaccine trials themselves as an advocacy programme.
The trials provide a lot of publicity, drive state
engagement, and provide people with the
opportunity to begin to engage with issues around
their fundamental needs, their rights with respect to
biomedical ethics, and essentially drive African
demand for a vaccine, at a political if not an
economic level. This is an important component of
IAVI’s work on access to a vaccine should it become
available. One interviewee from the East Africa
regional office stated:
I bet you that is what he (interviewees’ boss) is
doing right now, that’s why he is not in the office.
He’s sensitizing the community, and we define
community very broadly, and sensitizing the
community so that people are aware and people
understand that people are aware and people
understand that the vaccine does have a place in
HIV prevention, and when it becomes available
they will demand it from their governments and
their governments will demand it at the United
Nations, whatever forum is available to them to
make these demands for an HIV vaccine. And it’s
not stored on the shelf somewhere.
The interviewee went on to say that this view of
advocacy and trials as building demand was related to
decisions to locate trial sites in different African
countries rather than just concentrating efforts. ‘Just
being on the ground does create this awareness and
hopefully … in the end it will create this demand’.
IAVI’s advocacy work and its role in stimulating
awareness are widely acknowledged. An
independent evaluation in 2003 said:
IAVI has helped to raise the political profile of
HIV/AIDS. It has increased the attention of policy
makers to the need for an AIDS vaccine that
would meet the needs of developing countries
and that would be available simultaneously
throughout the world … IAVI has begun to
involve developing country policy makers,
scientists, and civil society in AIDS vaccine efforts
in essential ways in which they never involved
before. While doing all of this, IAVI has also been
the world leader in providing information on
AIDS vaccines. (Skolnik 2003)
Whether or not IAVI succeeds in its overall mission
or is judged over the longer term as a success will of
course depend on many factors.2 We would certainly
not want to suggest that the IAVI approach is a
blueprint or that it is guaranteed success. The sources
of risk and uncertainty are of course both scientific
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and social; overall success will depend on many
factors. Even if a vaccine does result, the ability to
deliver and distribute it may well depend on having
viable health systems in poor countries which do not
currently enjoy even the basics of healthcare
provision.
An emphasis on communications, spanning both
public relations and advocacy, seem to have pushed
IAVI in the direction of real engagement with
partners in developing countries and to a broader
approach to its partnerships than might have been
expected.3 Of course, this engagement and
participation is also fundamental to carrying out
clinical trials. A strong communications strategy,
based on the need to gain support has led to more
participation. This is important to IAVI primarily
because of ‘productivity’ concerns and yet there are
very obvious ‘entitlement’ consequences and
implications for various stakeholders.
We have suggested that because IAVI needs to
communicate its message about HIV/AIDS and in
arguing for the importance and possibility of a
vaccine it has created to some extent a participative
structure. The organisation needs to be seen to
respond to the voice of many stakeholders. The
success of its clinical trials work depends on the
effectiveness in communicating clearly about the
potential benefits of trials and the risks involved, and
in ensuring the participation of people in trials work.
It is held to account by states, NGOs, community-
based organisations (CBOs) and regulators with
respect to the clinical trials works.
6 Conclusions: reflections on innovation
systems, exit voice and loyalty in IAVI
IAVI is not trying to create an AIDS vaccine for
developing countries simply by investing in science.
While a great deal of its financial resource is devoted
to the science, building routes through to market
and addressing issues of acceptance of a vaccine are
very high priorities. In this regard, IAVI’s approach to
vaccine development is certainly based on trying to
address the problem of product development and
acceptance from a more systemic approach. It is
aware that it needs to consider production and
distribution issues across the value chain. Additionally,
because it is heavily monitored and relies on goodwill
and consent-based engagement of clinical trials
participants, IAVI needs to build community-based
structures into its work. Feedback mechanisms and a
non-linear approach to vaccine development are
evident and from an innovation systems base all can
be judged to be positive. However, there are a series
of questions relating to innovation systems analysis
that are unclear. These include the following.
What is the relationship between what IAVI does at
the micro level and broader dynamics in different
contexts? Is IAVI having an impact on the wider
innovation and health systems environments?
What are the significant constraints and debates about
IAVI in different contexts? Do the dynamics between
participation at grassroots level and the overall
communication strategies vary in different locations?
What are the properties and capacities within IAVI
that allow it to act as a development actor and
innovator? What are the tensions and is IAVI able to
fully combine activities successfully?4
If there are unanswered questions about IAVI in
relation to an innovation systems framework there
are far more in relation to Hirschman’s framework of
exit, voice and loyalty and in relation to institutional
development. Nevertheless, Hirschman’s framework
is useful because it offers a way to structure
thoughts about the way participation may and may
not relate to broader organisational and institutional
change. While our thinking about the exit, voice and
loyalty in relation to IAVI is schematic it does allow
for a tentative story to emerge and provides the
groundwork for more analytical and focused
questions to be developed.
One of our main suggestions is that IAVI works to
secure engagement (builds loyalty) because it needs to
gain approval from many individuals, organisations and
institutions at many levels. It operates under the threat
of ‘exit’ by donors, partners and a wide range of
collaborators and supporters in different contexts.
Thus, it works to secure loyalty by creating a
sophisticated communications strategy. To some
extent, participation is explicitly addressed in a broader
communications strategy, which values and needs to
take seriously ‘voice’ from the grassroots and other
organisations, this being a requisite from donors and
collaborators. Channels within IAVI and IAVI’s
communication with others and IAVI’s thinking about
its relations with others are to some extent influenced
by participation efforts. Here, it is important that IAVI
is operational in a context where it is working in
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democracies and is heavily monitored by national and
international bodies. Voice here has both productivity
and entitlement consequences which are clearly
intertwined but on the basis of this work and within
the confines of this initial exploration this remains
territory to be further investigated.
Exit is a very real option for individuals and
organisations involved particularly in the clinical trials
work and exit is to some extent perhaps enhanced by
working to strengthen not only work in vaccines
(where there are a very limited number of
organisations and thus not much ‘choice’) but also for
prevention and care. Thus, individuals and
governments could opt to support other approaches
to the disease. Using our earlier distinction, we could
say that IAVI is developing ‘communication for
participation’ and this yields some positive impacts on
its own organisational development and on broader
institutional development. However, this a rosy
picture and there may well be complications and
contradictions in this story which have not fully come
out in fieldwork to date. For example, in some
instances, efforts to secure loyalty may actually block
‘voice’ and participation; ‘spin’ may take over from real
engagement. It may also be that IAVI’s dominance in
some places may reduce ‘exit’ options – if IAVI is or
comes to be seen as so dominant that it is not open
to challenge, this may reduce people’s willingness to
engage and it may reduce IAVI’s responsiveness.
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Notes
1 Other relevant categorisations have been
developed by Agarwal (2001), Gaventa (2002) and
Cornwall (2002).
2 Some consider that IAVI’s approach to intellectual
property whereby IAVI insists on having
controlling rights over projects that it invests in
will hamper its success in the long run. Whether
or not it is true, it is important here to note that
IAVI does stipulate boundaries within which
communication takes place.
3 In another article, we have also written about
how IAVI’s approach to technical communication
between partners and the priority it gives to
‘tacit’ knowledge communication has resulted in
capacity building (Chataway and Smith 2006).
4 We have begun to look at these issues in a recent
publication: e.g. see Special Issue on Vaccines and
Development of the International Journal of
Technology Management and Sustainable
Development (Chataway et al. 2007b: 6/1).
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